Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
1 other identifier
observational
2,000
1 country
1
Brief Summary
The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2024
CompletedFirst Submitted
Initial submission to the registry
June 1, 2025
CompletedFirst Posted
Study publicly available on registry
June 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 19, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 19, 2027
June 12, 2025
June 1, 2025
3 years
June 1, 2025
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Modified Rankin Scale Score
Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.
90±7 days
Secondary Outcomes (7)
Modified Rankin Scale Score
7±1 days or the day discharged
Modified Rankin Scale Score
365±30 days
Perioperative complication rate
30±7 days
Rate of cardiovascular and cerebrovascular events
90±7 days
Rate of cardiovascular and cerebrovascular events
365±30 days
- +2 more secondary outcomes
Study Arms (5)
Neuro-co-cardiological diseases: Simultaneous treatment
Simultaneous interventional therapy/Simultaneous surgical treatment/ Simultaneous hybrid surgical treatment
Neuro-co-cardiological diseases: Staged treatment
Staged interventional therapy/Staged surgical treatment/Staged hybrid surgical treatment
Neuro-co-cardiological diseases: Conservative treatment
Surgery/intervention for one disease and conservative treatment for another disease or Simultaneously conservative treatment
Post-cardiac surgery Cerebrovascular disease: Surgery/Interventional Treatment
Post-cardiac surgery Cerebrovascular disease: Surgery/Interventional Treatment
Post-cardiac surgery Cerebrovascular disease: Conservative treatment
Post-cardiac surgery Cerebrovascular disease: Conservative treatment
Interventions
Simultaneous interventional or surgical treatment/staged interventional or surgical treatment
Eligibility Criteria
Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases
You may qualify if:
- Age ≥18 years;
- Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.
You may not qualify if:
- The expected survival is less than 1 years;
- Simultaneously merge other serious diseases;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Anzhen Hospital
Beijing, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
June 1, 2025
First Posted
June 10, 2025
Study Start
September 19, 2024
Primary Completion (Estimated)
September 19, 2027
Study Completion (Estimated)
September 19, 2027
Last Updated
June 12, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share